DAY ONE BIOPHARMACEUTICALS I (DAWN) Stock Cash Flow
NASDAQ:DAWN - Nasdaq - US23954D1090 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -95.50M | -188.92M | -142.18M | -72.75M | -43.84M | |||
| Depreciation Amortization | 1.56M | 36.00K | 60.00K | 20.00K | 20.00K | |||
| Change In Working Capital | 26.48M | 9.42M | 6.56M | 2.70M | -360.00K | |||
| Taxes Paid | 1.90M | N/A | N/A | N/A | N/A | |||
| Other non cash items | -10.66M | 32.61M | 25.68M | 21.50M | 30.70M | |||
| OPERATING CASH FLOW | -78.11M | -146.85M | -109.87M | -48.54M | -13.49M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -19.27M | -224.00K | -30.00K | 0.00 | -90.00K | |||
| Other Investing Activity | -211.72M | 128.60M | -255.05M | -8.00M | N/A | |||
| INVESTING CASH FLOW | -230.99M | 128.38M | -255.07M | -8.00M | -90.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 25.11M | 164.00M | 165.90M | 297.12M | 29.98M | |||
| Other Financing Activity | 178.18M | N/A | N/A | 0.00 | 0.00 | |||
| FINANCING CASH FLOW | 203.29M | 164.00M | 165.90M | 297.12M | 29.98M | |||
| CHANGE IN CASH | -105.82M | 145.52M | -199.04M | 240.58M | 16.40M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -78.11M | -146.85M | -109.87M | -48.54M | -13.49M | |||
| Capital Expenditure | -19.27M | -224.00K | -30.00K | 0.00 | -90.00K | |||
| FREE CASH FLOW | -97.38M | -147.08M | -109.90M | -48.54M | -13.58M | |||
All data in USD